GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fractyl Health Inc (NAS:GUTS) » Definitions » Debt-to-Revenue

Fractyl Health (Fractyl Health) Debt-to-Revenue : 458.58 (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Fractyl Health Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Fractyl Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $3.59 Mil. Fractyl Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $56.94 Mil. Fractyl Health's annualized Revenue for the quarter that ended in Mar. 2024 was $0.13 Mil. Fractyl Health's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 458.58.


Fractyl Health Debt-to-Revenue Historical Data

The historical data trend for Fractyl Health's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fractyl Health Debt-to-Revenue Chart

Fractyl Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
N/A N/A N/A N/A 719.93

Fractyl Health Quarterly Data
Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 130.23 385.49 3,085.39 458.58

Competitive Comparison of Fractyl Health's Debt-to-Revenue

For the Biotechnology subindustry, Fractyl Health's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fractyl Health's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fractyl Health's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Fractyl Health's Debt-to-Revenue falls into.



Fractyl Health Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Fractyl Health's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2.731 + 83.66) / 0.12
=719.93

Fractyl Health's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.592 + 56.941) / 0.132
=458.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Fractyl Health Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fractyl Health's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Fractyl Health (Fractyl Health) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
17 Hartwell Avenue, Lexington, MA, USA, 02421
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity.